These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 6202716)
21. The distinct roles that Gln-192 and Glu-217 of factor IX play in selectivity for macromolecular substrates and inhibitors. Hsu YC; Hamaguchi N; Chang YJ; Lin SW Biochemistry; 2001 Sep; 40(37):11261-9. PubMed ID: 11551226 [TBL] [Abstract][Full Text] [Related]
22. Intrinsic procoagulant surface induced by hypercholesterolaemia on rabbit aortic endothelium. Lupu F; Moldovan N; Ryan J; Stern D; Simionescu N Blood Coagul Fibrinolysis; 1993 Oct; 4(5):743-52. PubMed ID: 8292724 [TBL] [Abstract][Full Text] [Related]
23. Thrombin and haemostasis: regulation of the biological functions of thrombin. (Facts and perspectives). Machovich R; Horváth I Haematologia (Budap); 1981 Dec; 14(4):339-59. PubMed ID: 6178655 [TBL] [Abstract][Full Text] [Related]
24. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Hoffman M; Monroe DM; Oliver JA; Roberts HR Blood; 1995 Sep; 86(5):1794-801. PubMed ID: 7655009 [TBL] [Abstract][Full Text] [Related]
25. Apparent intrinsic prothrombinase activity of human Factor X zymogen: identification with Factor VIII inhibitor bypassing activity (FEIBA). Estry DW; Tishkoff GH Thromb Res; 1984 Dec; 36(6):549-62. PubMed ID: 6335607 [TBL] [Abstract][Full Text] [Related]
26. Localization of an antithrombin exosite that promotes rapid inhibition of factors Xa and IXa dependent on heparin activation of the serpin. Izaguirre G; Zhang W; Swanson R; Bedsted T; Olson ST J Biol Chem; 2003 Dec; 278(51):51433-40. PubMed ID: 14532267 [TBL] [Abstract][Full Text] [Related]
27. Residues Tyr253 and Glu255 in strand 3 of beta-sheet C of antithrombin are key determinants of an exosite made accessible by heparin activation to promote rapid inhibition of factors Xa and IXa. Izaguirre G; Olson ST J Biol Chem; 2006 May; 281(19):13424-13432. PubMed ID: 16517611 [TBL] [Abstract][Full Text] [Related]
28. In vivo metabolism of inter-alpha-trypsin inhibitor and its proteinase complexes: evidence for proteinase transfer to alpha 2-macroglobulin and alpha 1-proteinase inhibitor. Pratt CW; Pizzo SV Arch Biochem Biophys; 1986 Aug; 248(2):587-96. PubMed ID: 2427028 [TBL] [Abstract][Full Text] [Related]
29. Cellular internalization and degradation of antithrombin III-thrombin, heparin cofactor II-thrombin, and alpha 1-antitrypsin-trypsin complexes is mediated by the low density lipoprotein receptor-related protein. Kounnas MZ; Church FC; Argraves WS; Strickland DK J Biol Chem; 1996 Mar; 271(11):6523-9. PubMed ID: 8626456 [TBL] [Abstract][Full Text] [Related]
30. Association of alpha 2-macroglobulin-thrombin and alpha 2-macroglobulin-plasmin complexes with isolated hepatocytes. Spolarics Z; Mandl J; Machovich R; Lambin P; Garzó T; Antoni F; Horváth I Biochim Biophys Acta; 1985 Jun; 845(3):389-95. PubMed ID: 2408676 [TBL] [Abstract][Full Text] [Related]
31. The binding of factor IXa to cultured bovine aortic endothelial cells. Induction of a specific site in the presence of factors VIII and X. Stern DM; Nawroth PP; Kisiel W; Vehar G; Esmon CT J Biol Chem; 1985 Jun; 260(11):6717-22. PubMed ID: 3922979 [TBL] [Abstract][Full Text] [Related]
32. Identification of a factor IX/IXa binding protein on the endothelial cell surface. Rimon S; Melamed R; Savion N; Scott T; Nawroth PP; Stern DM J Biol Chem; 1987 May; 262(13):6023-31. PubMed ID: 3032954 [TBL] [Abstract][Full Text] [Related]
33. Characterization of the clotting activities of structurally different forms of activated factor IX. Enzymatic properties of normal human factor IXa alpha, factor IXa beta, and activated factor IX Chapel Hill. Griffith MJ; Breitkreutz L; Trapp H; Briet E; Noyes CM; Lundblad RL; Roberts HR J Clin Invest; 1985 Jan; 75(1):4-10. PubMed ID: 3871202 [TBL] [Abstract][Full Text] [Related]
34. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation. Pieters J; Willems G; Hemker HC; Lindhout T J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615 [TBL] [Abstract][Full Text] [Related]
35. An alpha 2-macroglobulin receptor-dependent mechanism for the plasma clearance of transforming growth factor-beta 1 in mice. LaMarre J; Hayes MA; Wollenberg GK; Hussaini I; Hall SW; Gonias SL J Clin Invest; 1991 Jan; 87(1):39-44. PubMed ID: 1702100 [TBL] [Abstract][Full Text] [Related]
36. Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin. Osterud B; Rapaport SI Scand J Haematol; 1980 Mar; 24(3):213-26. PubMed ID: 7375819 [TBL] [Abstract][Full Text] [Related]
37. Properties of the factor Xa binding site on human platelets. Miletich JP; Jackson CM; Majerus PW J Biol Chem; 1978 Oct; 253(19):6908-16. PubMed ID: 690132 [TBL] [Abstract][Full Text] [Related]
38. Characterization of the interaction between factor Xa and bovine aortic endothelial cells. Rodgers GM; Shuman MA Biochim Biophys Acta; 1985 Mar; 844(3):320-9. PubMed ID: 3970981 [TBL] [Abstract][Full Text] [Related]
39. Cleavage at arginine 145 in human blood coagulation factor IX converts the zymogen into a factor VIII binding enzyme. Lenting PJ; ter Maat H; Clijsters PP; Donath MJ; van Mourik JA; Mertens K J Biol Chem; 1995 Jun; 270(25):14884-90. PubMed ID: 7797466 [TBL] [Abstract][Full Text] [Related]
40. Alpha-2-macroglobulin is an important progressive inhibitor of thrombin in neonatal and infant plasma. Schmidt B; Mitchell L; Ofosu FA; Andrew M Thromb Haemost; 1989 Dec; 62(4):1074-7. PubMed ID: 2482548 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]